• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Purification, assay and kinetic features of HIV-1 proteinase.

作者信息

Billich A, Hammerschmid F, Winkler G

机构信息

Sandoz-Forschungsinstitut, Wien.

出版信息

Biol Chem Hoppe Seyler. 1990 Mar;371(3):265-72.

PMID:2187485
Abstract
  1. The aspartic proteinase of the human immunodeficiency virus type 1 (HIV-1) was purified from cultures of recombinant E. coli. The enzyme preparation is homogeneous as judged by SDS-polyacrylamide gel electrophoresis and isoelectric focusing. 2) A rapid assay procedure for the proteinase was established which makes use of the cleavage of a radiolabeled decapeptide and the separation of substrate and labeled product by ion-exchange resin. 3) Activity of the enzyme is optimal at an ionic strength of 2.5-3.5M; also, the inhibitor pepstatin is a more potent inhibitor at higher ionic strength. This can be attributed to a tighter binding of both substrate and inhibitor in high-salt buffer. 4) The Km value of the decapeptide substrate is independent of the pH in the range of 3.5-7.5, while kcat shows a bell-shaped curve with a maximum at pH 5.2. The shape of the curve can be attributed to pKa values of 4.2 and 6.2 of groups on the enzyme. Pepstatin inhibition is optimal below pH 5.5, but becomes weak above pH 6.
摘要

相似文献

1
Purification, assay and kinetic features of HIV-1 proteinase.
Biol Chem Hoppe Seyler. 1990 Mar;371(3):265-72.
2
Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.从大肠杆菌中纯化的1型人类免疫缺陷病毒(HIV - 1)蛋白酶前体和成熟形式的表征及自加工
Proteins. 1989;6(2):139-54. doi: 10.1002/prot.340060205.
3
Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.
Biochem Biophys Res Commun. 1990 Aug 31;171(1):60-6. doi: 10.1016/0006-291x(90)91356-w.
4
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.纯化重组HIV-1蛋白酶的底物类似物抑制和活性位点滴定
Biochemistry. 1990 Jan 9;29(1):264-9. doi: 10.1021/bi00453a036.
5
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.重组猿猴免疫缺陷病毒蛋白酶的纯化及生化特性分析,并与1型人类免疫缺陷病毒蛋白酶进行比较。
Biochemistry. 1991 Aug 27;30(34):8424-34. doi: 10.1021/bi00098a021.
6
Two new pepsin proteases of microbial origin.两种新的微生物源胃蛋白酶蛋白酶。
Microbiol Sci. 1988 Jun;5(6):190-1.
7
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.重组HIV2蛋白酶在体外加工HIV1 Pr53gag和类似的连接肽。
J Biol Chem. 1990 Aug 15;265(23):13890-8.
8
Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.人类免疫缺陷病毒1型感染的母婴中,HIV-1蛋白酶、Gag p7和p6以及gag/pol多蛋白内蛋白酶切割位点的自然变异:无蛋白酶抑制剂情况下的氨基酸替代
Virology. 1996 May 15;219(2):407-16. doi: 10.1006/viro.1996.0266.
9
Expression and purification of active form of HIV-1 protease from E.coli.从大肠杆菌中表达并纯化HIV-1蛋白酶的活性形式。
Biochem Mol Biol Int. 1995 Apr;35(4):899-912.
10
Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.HIV-1和HIV-2蛋白酶对合成显色底物的水解作用。
Biochem Biophys Res Commun. 1990 Aug 31;171(1):439-44. doi: 10.1016/0006-291x(90)91412-l.

引用本文的文献

1
The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation.HIV-1 衣壳蛋白通过相分离活性增强来调节自身的浓缩,从而在成熟过程中隔离病毒蛋白酶。
Viruses. 2021 Nov 19;13(11):2312. doi: 10.3390/v13112312.
2
HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.HIV-1 蛋白酶和逆转录酶控制其核衣壳伴侣的结构。
PLoS One. 2007 Aug 22;2(7):e669. doi: 10.1371/journal.pone.0000669.
3
A yeast-based growth assay for the analysis of site-specific proteases.
一种用于分析位点特异性蛋白酶的基于酵母的生长测定法。
Nucleic Acids Res. 2003 Feb 15;31(4):e16. doi: 10.1093/nar/gng016.
4
Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus.鱼类逆转录病毒——大眼梭鲈皮肤肉瘤病毒蛋白酶的特性研究
J Virol. 2002 May;76(9):4341-9. doi: 10.1128/jvi.76.9.4341-4349.2002.
5
Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.来自Gag-Pol多聚蛋白类似物的人类免疫缺陷病毒1型蛋白酶自身加工的动力学与机制
Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7970-4. doi: 10.1073/pnas.91.17.7970.
6
Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.SDZ NIM 811的作用机制,一种对1型人类免疫缺陷病毒(HIV)有活性的非免疫抑制性环孢菌素A类似物:干扰HIV与亲环蛋白A的相互作用。
J Virol. 1995 Apr;69(4):2451-61. doi: 10.1128/JVI.69.4.2451-2461.1995.
7
Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.SDZ NIM 811的作用机制,一种具有抗1型人类免疫缺陷病毒(HIV-1)活性的非免疫抑制性环孢菌素A类似物:干扰HIV-1复制的早期和晚期事件。
J Virol. 1995 Feb;69(2):814-24. doi: 10.1128/JVI.69.2.814-824.1995.
8
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.非免疫抑制性环孢素类似物SDZ NIM 811对1型人类免疫缺陷病毒复制的抑制作用。
Antimicrob Agents Chemother. 1994 Aug;38(8):1763-72. doi: 10.1128/AAC.38.8.1763.
9
SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety.SDZ PRI 053,一种口服生物可利用的1型人类免疫缺陷病毒蛋白酶抑制剂,含有2-氨基苄基司他汀部分。
Antimicrob Agents Chemother. 1995 Jul;39(7):1406-13. doi: 10.1128/AAC.39.7.1406.
10
beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.
Proc Natl Acad Sci U S A. 1990 Dec;87(24):10023-7. doi: 10.1073/pnas.87.24.10023.